HER-2 signaling, acquisition of growth factor independence, and regulation of biological networks associated with cell transformation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20736364.
- Also identified by DOI 10.1158/0008-5472.CAN-10-1529 and PMC identifier 3858175.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Activated oncogenes are the dominant drivers of malignant progression in human cancer, yet little is known about how the transformation from proto-oncogene to activated oncogene drives the expression of transformed phenotypes. An isogenic model of HER-2-mediated transformation of human mammary epithelial cells was used along with HER-2-amplified human breast cancers to investigate how HER-2 activation alters its properties as a signaling molecule and changes the networks of HER-2-regulated genes. Our results show that full oncogenic activation of HER-2 is the result of a transition in which activated HER-2 acquires dominant signaling properties that qualitatively alter the network of genes regulated by the activated oncogene compared with the proto-oncogene. Consequently, gene expression programs related to invasion, cell stress, and stemness become regulated by HER-2 in a manner not observed in nontransformed cells, even when HER-2 is overexpressed. Our results offer novel insights into biological processes that come under the control of HER-2 after it acquires full oncogenic potential.
Medical subject headings
- Cell Transformation, Neoplastic
- Intercellular Signaling Peptides and Proteins
- Erb-b2 Receptor Tyrosine Kinases